AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS

自闭症和 AMPS 裂解酶突变:细胞和小鼠模型

基本信息

项目摘要

DESCRIPTION (provided by applicant): Adenylosuccinate lyase (ADSL) catalyzes two steps of de novo purine biosynthesis. In 1984, a genetic syndrome was described in which a deficiency in ADSL leads to profound developmental delay and, in up to 30% of cases, autistic features (5). Currently, over 30 mutations in ADSL are known to cause ADSL deficiency. The clinical picture in these individuals can vary widely. Interestingly, in 2000 an ADSL deficiency patient was reported with minimal developmental delay and autistic features. (6) In 1987, we mapped the gene for ADSL to human chromosome 22 (29). The precise location of the ADSL gene is now known to be in the 22q13 region. Chromosomal anomalies in this region are also associated with autism. This data suggests that ADSL deficiency is a contributing factor to autism as well as to psychomotor delay and mental retardation. Autism affects approximately 1 in 2000 individuals. Defining features are impaired sociability, language and communication, and range of interests and activities. Mental deficiency may or may not be present, and the cognitive profile is narrow, occasionally with superior but narrow talent. Perseveration, concreteness, affective blunting, and lack of insight into other persons' thinking may be present. We have isolated and extensively characterized a Chinese hamster ovary cell (CHO-K1) cell mutant, Adel, completely lacking in ADSL activity. We now propose to create and characterize a mouse model of ADSL deficiency. For this purpose, we will inactivate the mouse ADSL gene by targeted mutagenesis. We will then introduce the wild type and selected mutant human ADSL genes into different lines of transgenic mice and by appropriate breeding create mice carrying only the wild type or mutant forms of human ADSL. We will produce mice with the R426H mutation that leads to severe developmental delay, often with autistic features, and the R303C mutation that leads to mild disease. These mice will then be analyzed neuroanatomically, biochemically, physiologically, and behaviorally to understand the consequences of ADSL mutations. We will then attempt to intervene with appropriate pharmacological agents to reverse the effects of ADSL deficiency, and, we hope, to other forms of autism.
描述(由申请人提供):腺苷琥珀酸裂解酶(ADSL)催化两个步骤的从头嘌呤生物合成。1984年,一种遗传综合征被描述为ADSL缺陷导致严重的发育迟缓,在高达30%的病例中,出现自闭症特征(5)。目前,已知超过30种ADSL突变会导致ADSL缺陷。这些个体的临床表现差异很大。有趣的是,2000年报告了一名ADSL缺陷患者,其发育迟缓和自闭症特征极小。(6) 1987年,我们将ADSL基因定位到人类22号染色体上。目前已知ADSL基因的精确位置在22q13区域。该区域的染色体异常也与自闭症有关。这些数据表明,ADSL缺陷是自闭症以及精神运动迟缓和智力迟钝的一个促成因素。大约每2000人中就有1人患有自闭症。主要特征是社交能力、语言和沟通能力、兴趣和活动范围受损。智力缺陷可能存在,也可能不存在,认知轮廓很狭窄,偶尔有优秀但狭窄的才能。顽固、具体、情感迟钝和缺乏对他人思想的洞察力可能是存在的。我们分离并广泛表征了一种完全缺乏ADSL活性的中国仓鼠卵巢细胞(CHO-K1)突变体Adel。我们现在建议建立并表征ADSL缺陷的小鼠模型。为此,我们将通过靶向诱变使小鼠ADSL基因失活。然后,我们将野生型和选择的突变型人类ADSL基因引入不同的转基因小鼠系,并通过适当的育种创造出只携带野生型或突变型人类ADSL的小鼠。我们将生产具有R426H突变的小鼠,这种突变会导致严重的发育迟缓,通常具有自闭症特征,而R303C突变会导致轻微的疾病。然后对这些小鼠进行神经解剖学、生物化学、生理学和行为学分析,以了解ADSL突变的后果。然后,我们将尝试用适当的药物干预来扭转ADSL缺陷的影响,我们希望,对其他形式的自闭症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID PATTERSON其他文献

DAVID PATTERSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID PATTERSON', 18)}}的其他基金

Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
  • 批准号:
    7248057
  • 财政年份:
    2004
  • 资助金额:
    $ 24.26万
  • 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
  • 批准号:
    6926190
  • 财政年份:
    2004
  • 资助金额:
    $ 24.26万
  • 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
  • 批准号:
    7082872
  • 财政年份:
    2004
  • 资助金额:
    $ 24.26万
  • 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
  • 批准号:
    6826136
  • 财政年份:
    2004
  • 资助金额:
    $ 24.26万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    6579811
  • 财政年份:
    2003
  • 资助金额:
    $ 24.26万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    6703721
  • 财政年份:
    2003
  • 资助金额:
    $ 24.26万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    7172954
  • 财政年份:
    2003
  • 资助金额:
    $ 24.26万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    7012827
  • 财政年份:
    2003
  • 资助金额:
    $ 24.26万
  • 项目类别:
PURINE, FOLATE, AND REACTIVE OXYGEN METABOLISM AND DOWN SYNDROME
嘌呤、叶酸和活性氧代谢与唐氏综合症
  • 批准号:
    6301897
  • 财政年份:
    2000
  • 资助金额:
    $ 24.26万
  • 项目类别:
CONFERENCE--NEW DIRECTIONS IN DOWN SYNDROME RESEARCH
会议——唐氏综合症研究的新方向
  • 批准号:
    6190811
  • 财政年份:
    2000
  • 资助金额:
    $ 24.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了